IRS1 and metabolic dysfunction-associated steatohepatitis: Although hepatic IRS-1 mRNA levels did not differ among the three groups (Fig. 1a), hepatic IRS-2 mRNA levels were significantly lower in the SS and NASH groups than in the controls (Fig. 1b).